Dysbiosis of the gut microbiota could stimulate an increase in the levels of inflammatory markers, such as TNF-α and CRP, leading to aberrant immune activation and chronic low-grade inflammation in individuals with T2DM (Frost et al., 2021; Rinninella et al., 2019). This evidence concerns the gene CRP and type 2 diabetes mellitus.